SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-251681
Filing Date
2023-10-05
Accepted
2023-10-05 17:28:30
Documents
15
Period of Report
2023-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d544800d8k.htm   iXBRL 8-K 34012
2 EX-1.1 d544800dex11.htm EX-1.1 200050
3 EX-5.1 d544800dex51.htm EX-5.1 9703
7 GRAPHIC g544800g1005081050414.jpg GRAPHIC 2409
  Complete submission text file 0001193125-23-251681.txt   435825

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eq-20231003.xsd EX-101.SCH 2847
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20231003_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20231003_pre.xml EX-101.PRE 11707
9 EXTRACTED XBRL INSTANCE DOCUMENT d544800d8k_htm.xml XML 3512
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 231312241
SIC: 2834 Pharmaceutical Preparations